Publication
A Mixed-Ligand Approach Enables the Asymmetric Hydrogenation of an α-Isopropylcinnamic Acid en Route to the Renin Inhibitor Aliskiren
Boogers, J. A. F., Felfer, U., Kotthaus, M., Lefort, L., Steinbauer, G., Vries, A. H. M. D. & Vries, J. G. D., 2007, In : Organic Process Research & Development. 11, 3, 7 p.Research output: Contribution to journal › Article › Academic
APA
Author
Harvard
Standard
A Mixed-Ligand Approach Enables the Asymmetric Hydrogenation of an α-Isopropylcinnamic Acid en Route to the Renin Inhibitor Aliskiren. / Boogers, Jeroen A.F.; Felfer, Ulfried; Kotthaus, Martina; Lefort, Laurent; Steinbauer, Gerhard; Vries, André H.M. de; Vries, Johannes G. de.
In: Organic Process Research & Development, Vol. 11, No. 3, 2007.Research output: Contribution to journal › Article › Academic
Vancouver
BibTeX
}
RIS
TY - JOUR
T1 - A Mixed-Ligand Approach Enables the Asymmetric Hydrogenation of an α-Isopropylcinnamic Acid en Route to the Renin Inhibitor Aliskiren
AU - Boogers, Jeroen A.F.
AU - Felfer, Ulfried
AU - Kotthaus, Martina
AU - Lefort, Laurent
AU - Steinbauer, Gerhard
AU - Vries, André H.M. de
AU - Vries, Johannes G. de
N1 - Relation: https://www.rug.nl/scheikunde/ date_submitted:2007 Rights: University of Groningen. Stratingh Institute
PY - 2007
Y1 - 2007
N2 - An asymmetric hydrogenation process for an α-isopropyl dihydrocinnamic acid derivative, an intermediate for the renin inhibitor aliskiren, has been developed using a rhodium catalyst ligated with a chiral monodentate phosphoramidite and a nonchiral phosphine. Whereas catalysts based on two equivalents of monodentate phosphoramidites gave promising results, the rate of hydrogenation and ee of the product could be improved spectacularly by the addition of monodentate nonchiral triarylphosphines to these catalysts. This remarkable mixed-ligand catalyst has been identified using high-throughput experimentation. With the best catalysts turnover numbers >5000 mol mol-1, turnover frequencies >1000 mol mol-1 h-1, and ee’s up to 95% have been achieved.
AB - An asymmetric hydrogenation process for an α-isopropyl dihydrocinnamic acid derivative, an intermediate for the renin inhibitor aliskiren, has been developed using a rhodium catalyst ligated with a chiral monodentate phosphoramidite and a nonchiral phosphine. Whereas catalysts based on two equivalents of monodentate phosphoramidites gave promising results, the rate of hydrogenation and ee of the product could be improved spectacularly by the addition of monodentate nonchiral triarylphosphines to these catalysts. This remarkable mixed-ligand catalyst has been identified using high-throughput experimentation. With the best catalysts turnover numbers >5000 mol mol-1, turnover frequencies >1000 mol mol-1 h-1, and ee’s up to 95% have been achieved.
U2 - 10.1021/op0602369
DO - 10.1021/op0602369
M3 - Article
VL - 11
JO - Organic Process Research and Development
JF - Organic Process Research and Development
SN - 1083-6160
IS - 3
ER -
ID: 2771273